Vaginal, Oral and Systemic Inflammation in Preterm Birth
NCT ID: NCT01142752
Last Updated: 2016-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
71 participants
OBSERVATIONAL
2011-11-30
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
No interventions will be carried out in this study.
Hypotheses:
1. There is a common etiology between oral and vaginal inflammation
2. Bacterial species are similar in vagina and oral cavity
3. There are similar oral and systemic immune reactions which provoke preterm birth
4. Inflammatory markers are found in pregnant women at risk and get back to normal post partum In this matched case control study of pregnant women local, systemic and oral inflammation markers and bacterial load are assessed to find out interconnections between these body compartments to allow for explanation of the etiology of preterm birth.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Premature Gut Microbiome and the Influence on Neonatal Immunity, Brain Development and White Matter Injury
NCT03213275
The Role of Volatile Organic Compounds (VOCs), Airway Mucins and the Microbiome in the Early Prediction of Bronchopulmonary Dysplasia (BPD)
NCT06342752
Placental and Cord Blood Markers Associated With Premature Birth and Disorders of Premature Birth in Newborn Infants
NCT01439048
Risk Factors of Preterm Birth Born in Hospital:a Prospective Multicenter Case-control Study
NCT03602625
Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
NCT01607216
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Summary
The prevalence of preterm birth (PTB) is increasing. While intrauterine infections may be the primary cause of PTB, remote infections may also be part of the aetiology and risk for gestational complications. Predicting and identifying women at risk for delivering preterm is difficult. Comprehensive studies are needed to study all infectious and inflammatory processes that may be involved in birth complications. Social, ethnic and behavioural risks are part of the factors involved. Thus, case-control studies of infection in pregnancy must acknowledge and control for such other factors.
The oral cavity provides a unique study model of periodontal infection and inflammation. Gingivitis and periodontitis have been associated with an elevated risk for PTB. A large entity of bacteria including both aerobic and anaerobic bacteria competent to elicit a systemic hyper-inflammatory host immune response can be identified in periodontal infection. Inflammation of the gingival tissues increases in pregnancy. Knowledge obtained through studies of clinical parameters as well as studies of bacteria and cytokines in oral, vaginal and blood samples in pregnant women at risk for preterm birth would establish evidence-based background for successful clinical strategies to prevent or reduce the risk for PTB.
The objectives of the present matched case-control study of pregnant women are to investigate local and remote infection (microbiological analysis by culture, and DNA-DNA checkerboard) and inflammation (cytokine assays in samples from vaginal and oral samples), and routine clinical data in three groups of pregnant women:
I. Women medically considered at risk for and WITH actual preterm birth delivery
II. Women medically considered at risk for preterm birth delivery but who deliver WITHOUT birth complications
III. Women with a normal uneventful pregnancy (control group)
The investigators aim to test the following hypotheses regarding associations between oral infection and PTB:
I. There is a shared infectious aetiology between oral and vaginal infections (primary outcome)
II. In women at risk for PTB the vaginal and oral bacterial microbiota are similar
III. There are similar systemic and/or local inflammatory responses (haematogenous dissemination and bacteraemia, feto-maternal immune response) that can be induced by vaginal and/or oral infection, contributing to PTB.
IV. Elevated inflammatory markers are found at the onset of symptoms in pregnant women at risk for PTB and normalize after birth.
2. Current status in this field of research
2.1. Introduction
Preterm birth (PTB) is defined as delivery before 37 weeks of gestation and a birth weight of \< 2500 grams. PTB is the most important determinant of perinatal morbidity and mortality. Among those born before 32 weeks of gestation many children will suffer from lifelong sequelae of prematurity ranging from mild to severe developmental disorders.
3. Detailed Research Plan
3.1. Scientific objectives (Aims)
The investigators aim to test the following hypotheses regarding associations between oral infection and PTB:
I. There is a shared infectious aetiology between oral and vaginal infections (primary outcome)
II. In women at risk for PTB the vaginal and oral bacterial microbiota are similar
III. There are similar systemic and/or local inflammatory responses (haematogenous dissemination and bacteraemia, feto-maternal immune response) that can be induced by vaginal and/or oral infection, contributing to PTB
IV. Elevated inflammatory markers are found at the onset of symptoms in pregnant women at risk for PTB and normalize after birth
3.2. Patient grouping
The study design is a longitudinal, non-interventional case-control study of pregnant women including (I) a control group of women with uneventful pregnancy
(II) a group of women medically considered at risk for PTB and actually delivering preterm
(III) a group of women medically considered at risk for PTB but with uneventful pregnancy.
Subjects will be examined at three time points (I) within 18-34 weeks of pregnancy when they get symptomatic
(II) within two days after delivery and
(III) 4-6 weeks post-partum. This would allow the investigators to compare all examined parameters between and within groups over the defined time frame.
Due to the medical inclusion criteria clinical medical/dental examinators cannot be blinded. At the first examination the clinicians will not know whether subjects belong to group II or group III. All laboratory processes will, however, be performed with no knowledge of group assignment.
The investigators intend to enrol a total of 180 pregnant women with a clinically perceived risk for PTB or at no/low risk based on routine clinical assessment criteria. Consecutive consenting pregnant women seeking care at, or are being referred to the Frauenspital, University of Berne will be asked to participate when admitted to the prenatal care unit because of risks for PTB, e.g. shortening of the cervical length, preterm contractions or prelabor premature rupture of membranes. The investigators anticipate a 10% dropout rate. They intend to continuously match subjects in the control group to those in the risk groups.
Consenting women will receive study examinations as well as obstetric standard of care during pregnancy provided by medical faculty investigators. Dental faculty investigators at the Department of Periodontology, University of Bern will perform dental examinations, data and sample collections from the participating subjects at either the Clinics of the Dental School or at the Frauenspital for bedridden pregnant women. There will be no specific dental interventions as part of the study. The dentists who normally provide care for study subjects will continue to do so. There are currently no known dental procedures that can reduce the risk for PTB. Dental procedures during pregnancy are considered at low or no risk to the pregnant women or the fetus.
The investigators will collect information on all medical and dental treatments performed during pregnancy. They will assess obstetric and dental clinical conditions, using procedures that they follow in both clinics. The investigators will also assess bacteria and fungi in vaginal and oral compartments, and serum and local vaginal/oral inflammatory markers (cytokines and C-reactive protein). They recognize that genetic and socio-economic factors as well as ethnicity are important factors in risks for PTB. The control group will therefore be paired and matched for gestational age, ethnicity, age, parity and smoking. The investigators anticipate that some of these subjects in the assigned no risk control group may actually deliver with PTB. Only women who deliver uneventfully will be included in the control group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Control group of women with uneventful pregnancy
No interventions assigned to this group
Population at risk with preterm birth
Women medically considered at risk for PTB and actually delivering preterm
No interventions assigned to this group
Population at risk without preterm birth
Women medically considered at risk for PTB but with uneventful pregnancy
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent
Exclusion Criteria
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Insel Gruppe AG, University Hospital Bern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel V Surbek, Prof.
Role: STUDY_DIRECTOR
University women's hospital Bern
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Women's Hospital
Bern, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KEK091/10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.